Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
Adler SP, Lewis N, Conlon A, Christiansen MP, Al-Ibrahim M, Rupp R, Fu TM, Bautista O, Tang H, Wang D, Fisher A, Culp T, Das R, Beck K, Tamms G, Musey L; V160-001 Study Group.
Adler SP, et al. Among authors: conlon a.
J Infect Dis. 2019 Jul 2;220(3):411-419. doi: 10.1093/infdis/jiz141.
J Infect Dis. 2019.
PMID: 31535143
Clinical Trial.